Cormorant Asset Management »

Rapt Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 497k 24.85
2023-09-30 $5.4M 325k 16.62
2023-06-30 $6.1M 325k 18.70
2023-03-31 $12M 650k 18.35